title: [The use of Cardioxane in chemotherapy of malignant neoplasms in children].
abstract: Treatment with anthracycline antibiotics may have a toxic effect on the myocardium. The report deals with the results of application of a cardioprotector--cardioxan--in 38 children, aged 2-13 years, with malignant tumors treated, among other drugs, with doxorubicin. These data were compared with those on 33 pediatric patients who had received anthracycline antibiotics until 1994. No cardioxan-related complications were recorded whenever the instructions on the use were followed. The results are inconclusive because of the short duration of the study and examination being still incomplete.
authors.forename: S A
authors.initials: SA
authors.lastname: Safonova
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Punanov
authors.forename: V M
authors.initials: VM
authors.lastname: Dedukh
authors.forename: B A
authors.initials: BA
authors.lastname: Kolygin
mesh_terms: D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced / Q000517:prevention & control*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008297:Male; D011929:Razoxane / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D002317:Cardiovascular Agents; D011929:Razoxane